Blocking leukocyte influx and function to prevent chronic lung disease of prematurity

Pediatric Pulmonology

Volumn 35, Issue 5, 2003, Pages 335-341

  Auten, Richard L ^a   Ekekezie, Ikechukwu I ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchopulmonary dysplasia; Chemokine; Cytokine; Inflammation

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; COMPLEMENT COMPONENT C5A; CYTOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOTRIENE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CHRONIC LUNG DISEASE; HUMAN; INFLAMMATION; LEUKOCYTE; LUNG DYSPLASIA; LUNG INJURY; MACROPHAGE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUTROPHIL; OXYGEN THERAPY; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL;

CELL MOVEMENT; CHRONIC DISEASE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LEUKOCYTES; LUNG DISEASES; PNEUMONIA;

EID: 0038406353     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10275     Document Type: Article

References (82)

1. Sugiura M, McLullock PR, Wren S, Lawson RH, Froese AB. Ventilator pattern influences neutrofil influx and activation in atelectasis-prone rabbit lung. J Appl Physiol 1994;77:1355-1365.
2. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1995; 72:90-96.
3. Comittee on Fetus and Newborn, American Academy of Pediatrics. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002;109:330-338.
4. Halliday HL, Ehrenkranz RA. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2001:CD001145.
5. Dudley DJ. Pre-term labor: an intra-uterine inflammatory response syndrome? J Reprod Immunol 1997;36:93-109.
6. Offenbacher S, Lieff S, Boggess KA, Murtha AP, Madianos PN, Champagne CM, McKaig RG, Jared HL, Mauriello SM, Auten RL Jr., Herbert WN, Beck JD. Maternal periodontitis and prematurity. Part I: obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001;6:164-174.
7. Madianos PN, Lieff S, Murtha AP, Boggess KA, Auten RL Jr., Beck JD, Offenbacher S. Maternal periodontitis and prematurity. Part II: maternal infection and fetal exposure. Ann Periodontol 2001;6:175-182.
8. Watterberg KL, Scott SM, Naeye RL. Chorioamnionitis, cortisol, and acute lung disease in very low birth weight infants. Pediatrics 1997;99:6.
9. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97:210-215.
10. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, Martin C. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002;140:171-176.
11. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996;40:250-256.
12. Kotecha S. Cytokines in chronic lung disease of prematurity. Eur J Pediatr [Suppl] 1996;155:14-17.
13. Speer CP. New insights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonate 2001;79:205-209.
14. Jobe AH, Newnham JP, Willet KE, Moss TJ, Gore Ervin M, Padbury JF, Sly P, Ikegami M. Endotoxin-induced lung maturation in preterm lambs is not mediated by cortisol. Am J Respir Crit Care Med 2000;162:1656-1661.
15. Willet KE, Jobe AH, Ikegami M, Newnham J, Brennan S, Sly PD. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr Res 2000;48:782-788.
16. Lukacs NW, Ward PA. Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury. Adv Immunol 1996;62:257-304.
17. Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17:3-9.
18. Strieter RM, Kunkel SL, Keane MP, Standiford TJ. Chemokines in lung injury: Thomas A. Neff Lecture. Chest 1999;116:103-110.
19. Yi Es, Lee H. Suh YK, Tang W, Qi M, Yin S, Remick DG, Ulich TR. Experimental extrinsic allergic alveolitis and pulmonary angiitis induced by intratracheal or intravenous challenge with Corynebacterium parvum in sensitized rats. Am J Pathol 1996; 149:1303-1312.
20. Tang WW, Yi ES, Remick DG, Wittwer A, Yin S, Qi M, Ulich TR. Intratracheal injection of endotoxin and cytokines. IX. Contribution of CD11a/ICAM-1 to neutrophil emigration. Am J Physiol 1995;269:653-659.
21. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994;93:712-718.
22. Gahler A, Stallmach T, Schwaller J, Fey MF, Tobler A. Interleukin-8 expression by fetal and neonatal pulmonary cells in hyaline membrane disease and amniotic infection. Pediatr Res 2000;48:299-303.
23. Lorant DE, Albertine K, Bohnsack JF. Chronic lung disease of early infancy: role of neutrophils. In: Bland RD, Coalson J, editors. Chronic lung disease in early infancy. New York: Marcel Dekker; 2000. p 793-812.
24. Auten RL, Whorton MH, Nicholas Mason S. Blocking neutrophilinflux reduces DNA damage in hyperoxia-exposed newborn rat lung. Am J Respir Cell Mol Biol 2002;26:391-397.
25. Hoidal JR, Xu P, Huecksteadt T, Sanders KA, Pfeffer K, Sturrock AB. Lung injury and oxidoreductases. Environ Health Perspect [Suppl] 1998;106:1235-1239.
26. Shenoy PS, Uniyal S, Miura K, McColl C, Oravecz T, Morris VL, Chan BM. Betal integrin-extracellular matrix protein interaction modulates the migratory response to chemokine stimulation. Biochem Cell Biol 2001;79:399-407.
27. Jackson JC, Chi EY, Wilson CB, Truog WE, Teh EC, Hodson WA. Sequence of inflammatory cell migration into lung during recovery from hyaline membrane disease in premature newborn monkeys. Am Rev Respir Dis 1987;135:937-940.
28. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999;160:1333-1346.
29. Auten RL Jr., Mason SN, Tanaka DT, Welty-Wolf K, Whorton MH. Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am J Physiol Lung Cell Mol Physiol 2001;281:336-344.
30. O'Reilly MA, Staversky RJ, Watkins RH, Reed CK, de Mesy Jensen KL, Finkelstein JN, Keng PC. The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am J Respir Cell Mol Biol 2001;24:703-710.
31. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990;141:471-501.
32. Hunninghake GW, Gadek JE, Szapiel SV, Strumpf IJ, Kawanami O, Ferrans VJ, Keogh BA, Crystal RG. The human alveolar macrophage. Methods Cell Biol 1980;21:95-105.
33. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 1979;97:149-206.
34. Brain JD. Lung macrophages: how many kinds are there? What do they do? Am Rev Respir Dis 1988;137:507-509.
35. Maus UA, Koay MA, Delbeck T, Mack M, Ermert M, Ermert L, Blackwell TS, Christman JW, Schlondorff D, Seeger W, Lohmeyer J. Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice. Am J Physiol Lung Cell Mol Physiol 2002;282:1245-1252.
36. Fridovich I. Biological effects of the superoxide radical. Arch Biochem Biophys 1986;247:1-11.
37. Sibille Y, Naegel GP, Merrill WW, Young KR Jr., Care SB, Reynolds HY. Neutrophil chemotactic activity produced by nor mal and activated human bronchoalveolar lavage cells. J Lab Clin Med 1987;110:624-633.
38. Strieter RM, Kunkel SL, Keane MP, Standiford TJ. Chemokines in lung injury: Thomas A. Neff Lecture. Chest 1999;116:1035-1105.
39. Rozycki HJ, Comber PG, Huff TF. Cytokines and oxygen radicals after hyperoxia in preterm and term alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2002;282:1222-1228.
40. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79:319-326.
41. Shellito J, Esparza C, Armstrong C. Maintenance of the normal rat alveolar macrophage cell population. The roles of monocyte influx and alveolar macrophage proliferation in situ. Am Rev Respir Dis 1987;135:78-82.
42. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 1997;94:12053-12058.
43. Michalec L, Choudhury BK, Postlethwait E, Wild JS, Alam R, Lett-Brown M, Sur S. CCL7 and CXCL10 orchestrate oxidative stress-induced neutrophilic lung inflammation. J Immunol 2002; 168:846-852.
44. Baier RJ, Loggins J, Kruger TE. Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum. J Invest Med 2001;49:362-369.
45. Flory CM, Jones ML, Warren JS. Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1. Lab Invest 1993;69:396-404.
46. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr., Broxmeyer HE, Charo IF. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-2561.
47. Jones ML, Mulligan MS, Flory CM, Ward PA, Warren JS. Potential role of monocyte chemoattractant protein 1/JE in monocyte/macrophage-dependent IgA immune complex alveolitis in the rat. J Immunol 1992;149:2147-2154.
48. Bless NM, Huber-Lang M, Guo RF, Warner RL, Schmal H, Czermak BJ, Shanley TP, Crouch LD, Lentsch AB, Sarma V, Mulligan MS, Friedl HP, Ward PA. Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J Immunol 2000;164:2650-2659.
49. Deng H, Mason SN, Auten RL Jr. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 2000;162:2316-2323.
50. Frank L. Effects of oxygen on the newborn. Fed Proc 1985;44: 2328-2334.
51. Vozzelli MA, Mason SN, Whorton MH, Auten RL Jr. Anti-macrophage chemokine treatment prevents neutrophil and macrophage in hyperoxia-exposed newborn rat lung. Am J Physiol: Lung Cell Mol Physiol 2003. In press.
52. Ekekezie II, Thibeault DW, Garola RE, Truog WE. Monocyte chemoattractant protein-1 and its receptor CCR-2 in piglet lungs exposed to inhaled nitric oxide and hyperoxia. Pediatr Res 2001; 50:633-640.
53. D'Angio CT, LoMonaco MB, Chaudhry SA, Paxhia A, Ryan RM. Discordant pulmonary proinflammatory cytokine expression during acute hyperoxia in the newborn rabbit. Exp Lung Res 1999;25:443-465.
54. D'Angio CT, Johnston CJ, Wright TW, Reed CK, Finkelstein JN. Chemokine mRNA alterations in newborn and adult mouse lung during acute hyperoxia. Exp Lung Res 1998;24:685-702.
55. Vozzelli MA, Mason SN, Whorton MH, Auten RL Jr. Antimonocyte chemoattractant protein-1 (MCP-1) treatment prevents leukocyte accumulation in hyperoxia-exposed newborn rat lung. Pediatr Res 2001;49:297.
56. Tani K, Ogushi F, Takahashi H, Kawano T, Endo T, Sone S. Thrombin stimulates platelet-derived growth factor release by alveolar macrophages in rats - significance in bleomycin-induced pulmonary fibrosis. J Med Invest 1997;44:59-65.
57. Martinet Y, Menard O, Vaillant P, Vignaud JM, Martinet N. Cytokines in human lung fibrosis. Arch Toxicol [Suppl] 1996; 18:127-139.
58. Adamson IY, Prieditis H, Young L. Lung mesothelial cell and fibroblast responses to pleural and alveolar macrophage supernatants and to lavage fluids from crocidolite-exposed rats. Am J Respir Cell Mol Biol 1997;16:650-656.
59. Sherman MP, Truog WE. The role of pulmonary macrophages in chronic lung disease of early infancy. In: Bland RD, Coalson J, editors. Chronic lung disease in early infancy. New York: Marcel Dekker; 2000. p 813-839.
60. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000;96: 34-40.
61. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL. Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis. Exp Mol Pathol 2000;68:77-84.
62. Viscardi RM, Hasday JD, Gumpper KF, Taciak V, Campbell AB, Palmer TW. Cromolyn sodium prophylaxis inhibits pulmonary proinflammatory cytokines in infants at high risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med 1997;156: 1523-1529.
63. Lister P, Iles R, Shaw B, Ducharme F. Inhaled steroids for neonatal chronic lung disease. Cochrane Database Syst Rev 2000: CD002311.
64. Clark PL, Ekekezie II, Kaftan HA, Castor CA, Truog WE. Safety and efficacy of nitric oxide in chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2002;86:41-45.
65. Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, Walsh-Sukys MC, McCaffrey MJ, Cornfield DN, Bhutani VK, Cutter GR, Baier M, Abman SH. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet 1999;354:1061-1065.
66. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr., Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60-68.
67. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996; 271:40-47.
68. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, Peitzman AB, Billiar TR, Tweardy DJ. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 1998;187:917-928.
69. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651-4655.
70. Granger DN, Kubes P. Nitric oxide as anti-inflammatory agent. Methods Enzymol 1996;269:434-442.
71. Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyteendothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med 1998;25:404-433.
72. van der Vliet A, Eiserich JP, O'Neill CA, Halliwell B, Cross CE. Tyrosine modification by reactive nitrogen species: a closer look. Arch Biochem Biophys 1995;319:341-349.
73. Lo SK, Janakidevi K, Lai L, Malik AB. Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am J Physiol 1993;264:406-412.
74. Wink DA, Cook JA, Kim SY, Vodovotz Y, Pacelli R, Krishna MC, Russo A, Mitchell JB, Jourd'heuil D, Miles AM, Grisham MB. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem 1997;272:11147-11151.
75. Shanley TP, Warner RL, Ward PA. The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today 1995;1:40-45.
76. Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA. Effects of reactive oxygen and nitrogen metabolites on MCP-1-induced monocyte chemotactic activity in vitro. Am J Physiol 1999;277:543-549.
77. Zhang J, Velsor LW, Patel JM, Postlethwait EM, Block ER. Nitric oxide-induced reduction of lung cell and whole lung thioredoxin expression is regulated by NF-kappaB. Am J Physiol 1999; 277: 787-793.
78. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 1997;41:457-463.
79. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2001: CD000509.
80. Tomhave ED, Richardson RM, Didsbury JR, Menard L, Snyderman R, Ali H. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. J Immunol 1994;153:3267-3275.
81. Ali H, Richardson RM, Haribabu B, Snyderman R. Chemoattractant receptor cross-desensitization. J Biol Chem 1999;274: 6027-6030.
82. Asagoe K, Yamamoto K, Takahashi A, Suzuki K, Maeda A, Nohgawa M, Harakawa N, Takano K, Mukaida N, Matsushima K, Okuma M, Sasada M. Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha. J Immunol 1998;160:4518-4525.